Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Pulikottil-Jacob

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Advances in Therapy|February 16, 2026
Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc AnalysisWim A Wuyts, Francesco Bonella, Maurizio Scarpa, et al.
Advances in Therapy|October 12, 2017
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the DiseaseRobert Hodgson, Timothy Reason, David Trueman, et al.
International Journal of Cardiology|January 16, 2014
Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) programAileen Clarke, Ruth Pulikottil-Jacob, Martin Connock, et al.
BMJ Open|April 2, 2017
Interactive web-based pulmonary rehabilitation programme: a randomised controlled feasibility trialEmma Chaplin, Stacey Hewitt, Lindsay Apps, et al.
BMJ (Clinical Research Ed.)|March 11, 2015
Setting benchmark revision rates for total hip replacement: analysis of registry evidenceNgianga-Bakwin Kandala, Martin Connock, Ruth Pulikottil-Jacob, et al.
BMC Musculoskeletal Disorders|July 23, 2017
Job retention vocational rehabilitation for employed people with inflammatory arthritis (WORK-IA): a feasibility randomized controlled trialAlison Hammond, Rachel O'Brien, Sarah Woodbridge, et al.
Trials|November 23, 2015
A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility studyDavid J Bowrey, Melanie Baker, Vanessa Halliday, et al.
Orphanet Journal of Rare Diseases|April 11, 2025
Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairmentRaphael Schiffmann, James Turnbull, Robert Krupnick, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failureRuth Pulikottil-Jacob, Gaurav Suri, Martin Connock, et al.
Advances in Therapy|September 8, 2025
An Indirect Treatment Comparison of Avalglucosidase Alfa versus Cipaglucosidase Alfa Plus Miglustat in Patients with Late-Onset Pompe DiseaseMark E Roberts, Irina Proskorovsky, Patricia Guyot, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Advances in Therapy|February 16, 2026
Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc AnalysisWim A Wuyts, Francesco Bonella, Maurizio Scarpa, et al.
Advances in Therapy|October 12, 2017
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the DiseaseRobert Hodgson, Timothy Reason, David Trueman, et al.
International Journal of Cardiology|January 16, 2014
Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) programAileen Clarke, Ruth Pulikottil-Jacob, Martin Connock, et al.
BMJ Open|April 2, 2017
Interactive web-based pulmonary rehabilitation programme: a randomised controlled feasibility trialEmma Chaplin, Stacey Hewitt, Lindsay Apps, et al.
BMJ (Clinical Research Ed.)|March 11, 2015
Setting benchmark revision rates for total hip replacement: analysis of registry evidenceNgianga-Bakwin Kandala, Martin Connock, Ruth Pulikottil-Jacob, et al.
BMC Musculoskeletal Disorders|July 23, 2017
Job retention vocational rehabilitation for employed people with inflammatory arthritis (WORK-IA): a feasibility randomized controlled trialAlison Hammond, Rachel O'Brien, Sarah Woodbridge, et al.
Trials|November 23, 2015
A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility studyDavid J Bowrey, Melanie Baker, Vanessa Halliday, et al.
Orphanet Journal of Rare Diseases|April 11, 2025
Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairmentRaphael Schiffmann, James Turnbull, Robert Krupnick, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failureRuth Pulikottil-Jacob, Gaurav Suri, Martin Connock, et al.
Advances in Therapy|September 8, 2025
An Indirect Treatment Comparison of Avalglucosidase Alfa versus Cipaglucosidase Alfa Plus Miglustat in Patients with Late-Onset Pompe DiseaseMark E Roberts, Irina Proskorovsky, Patricia Guyot, et al.
Pageof 4